The following products have been found matching your search "with": 883
Or did you mean: antibody vials with caps | FIND ME THIS PAPER Ball et al. (2022): This study highlights the increased incidence of hypoglycemic episodes in diabetic patients, particularly those with Type 1 diabetes, due to disruptions in glucose homeostasis during fasting periods. The study unders | without | 3 ML ANTIBODY VIALS WITH CAPS | within | Multilazer Flow Cytometer with | Sysmex CBC with 5 part diff | sample Tubes 5 mL with cap
No results were found for the filter!
Pacific Blue™
CyFlow™ CD2 Pacific Blue™
| Antigen: | CD2 |
| Clone: | LT2 |
| Regulatory Status: | ASR |
| Target Species: | Human |
$525.00 USD
PE
CyFlow™ CD157 PE
| Antigen: | CD157 |
| Clone: | SY11B5 |
| Regulatory Status: | ASR |
| Target Species: | Human |
$445.00 USD
APC
CyFlow™ CD200 APC
| Antigen: | CD200 |
| Clone: | OX-104 |
| Regulatory Status: | ASR |
| Target Species: | Human |
$445.00 USD
PerCP-Cy5.5
CyFlow™ CD7 PerCP-Cy5.5
| Antigen: | CD7 |
| Clone: | 124-1D1 |
| Regulatory Status: | ASR |
| Target Species: | Human |
$595.00 USD
FITC
PE
CyFlow™ CD200 PE
| Antigen: | CD200 |
| Clone: | OX-104 |
| Regulatory Status: | ASR |
| Target Species: | Human |
$445.00 USD
Pacific Blue™
CyFlow™ CD7 Pacific Blue™
| Antigen: | CD7 |
| Clone: | 124-1D1 |
| Regulatory Status: | ASR |
| Target Species: | Human |
$525.00 USD
PE-DyLight™ 594
CyFlow™ CD20 PE-DyLight™ 594
| Antigen: | CD20 |
| Clone: | 2H7 |
| Regulatory Status: | ASR |
| Target Species: | Human |
$595.00 USD
PE
PE
CyFlow™ CD71 PE
| Antigen: | CD71 |
| Clone: | MEM-75 |
| Regulatory Status: | ASR |
| Target Species: | Human |
$445.00 USD
PE-DyLight™ 594
CyFlow™ CD123 PE-DyLight™ 594
| Antigen: | CD123 |
| Clone: | 6H6 |
| Regulatory Status: | ASR |
| Target Species: | Human |
$595.00 USD
PE-DyLight™ 594
CyFlow™ CD7 PE-DyLight™ 594
| Antigen: | CD7 |
| Clone: | 124-1D1 |
| Regulatory Status: | ASR |
| Target Species: | Human |
$595.00 USD